Citation Impact
Citing Papers
Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action
2000
Cardiac vagal control in depression: A critical analysis
2006
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Temporal Relation among Depression Symptoms, Cardiovascular Disease Events, and Mortality in End-Stage Renal Disease
2006
Haematological toxicity of drugs used in psychiatry
2007
Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression
2001
Human brain mechanisms of pain perception and regulation in health and disease
2005 Standout
Autonomic nervous system activity in emotion: A review
2010 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Drug resistance in brain diseases and the role of drug efflux transporters
2005
Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: The POSITIVE Study, a multicenter, prospective, single-blind, randomised controlled clinical trial
2010
Brain imaging of18F‐fallypride in normal volunteers: Blood analysis, distribution, test‐retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D‐2/D‐3 receptors
2002
Descending control of pain
2002 Standout
Decreased Hippocampal 5-HT2A Receptor Binding in Older Depressed Patients Using [18F]Altanserin Positron Emission Tomography
2004
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
2009
The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional Architecture
2016 Standout
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Hemispheric asymmetry reduction in older adults: The HAROLD model.
2002 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation
2008 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Psychedelics
2016 Standout
The adolescent brain and age-related behavioral manifestations
2000 Standout
Anterior Cingulate, Gyrus Rectus, and Orbitofrontal Abnormalities in Elderly Depressed Patients: An MRI-Based Parcellation of the Prefrontal Cortex
2004
Functional Neuroanatomical Substrates of Altered Reward Processing in Major Depressive Disorder Revealed by a Dopaminergic Probe
2005
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
2005 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia
2006
Efficacy of Kava Extract for Treating Anxiety: Systematic Review and Meta-Analysis
2000
Therapeutic Potential of Kava in the Treatment of Anxiety Disorders
2002
Clozapine and Olanzapine Are Associated With Food Craving and Binge Eating
2007
Insights into the ageing mind: a view from cognitive neuroscience
2004 Standout
In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders
2009
Psychological flexibility as a fundamental aspect of health
2010 Standout
The Use of Complementary and Alternative Therapies to Treat Anxiety and Depression in the United States
2001 Standout
Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In Vivo
2002
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Toward the future of psychiatric diagnosis: the seven pillars of RDoC
2013 Standout
Stress signalling pathways that impair prefrontal cortex structure and function
2009 Standout
Banana (Musa spp) from peel to pulp: Ethnopharmacology, source of bioactive compounds and its relevance for human health
2014 Standout
Association between dorsolateral prefrontal N-acetyl aspartate and depression in chronic back pain: an in vivo proton magnetic resonance spectroscopy study
2003
Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes
2001
Neuroimaging studies of mood disorders
2000
Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants
2001
How were new medicines discovered?
2011 Standout
Neurobiology of Depression
2002 Standout
The Mesolimbic Dopamine Reward Circuit in Depression
2006 Standout
A meta-analytic review of emotion recognition and aging: Implications for neuropsychological models of aging
2008 Standout
Major Depressive Disorder
2008 Standout
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
2004 Standout
Cytokines and schizophrenia: Microglia hypothesis of schizophrenia
2009
Comorbidity of insomnia and depression
2009
Reconsidering anhedonia in depression: Lessons from translational neuroscience
2010
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
2011 Standout
C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications
2015
The Neuroendocrinology of Stress: A Never Ending Story
2008 Standout
Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls
2003
Herb-Drug Interactions
2005 Standout
Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?
2001
Probing Brain Reward System Function in Major Depressive Disorder
2002
Herbal Medicines and Perioperative Care
2001 Standout
Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies
2011 Standout
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
2007 Standout
Vagal withdrawal to a sad film predicts subsequent recovery from depression
2005
Interactions Between Herbal Medicines and Prescribed Drugs
2001 Standout
Moderate exercise and chronic stress produce counteractive effects on different areas of the brain by acting through various neurotransmitter receptor subtypes: A hypothesis
2006
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice
2011 Standout
Covariance‐based subdivision of the human striatum using T1‐weighted MRI
2008
Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis
2010 Standout
The polyvagal perspective
2006 Standout
Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression
1999
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
2012 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Dopamine Reuptake Inhibition in the Rostral Agranular Insular Cortex Produces Antinociception
1999
Hemispheric asymmetry reduction in older adults: The HAROLD model.
2002 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia
2005
Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders
2011
Operational criteria and factors related to recovery from schizophrenia
2002
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Dopamine D2-Like Receptors and the Antidepressant Response
2006
Biomedical Importance of Indoles
2013 Standout
Kava extract versus placebo for treating anxiety
2003
The organization of the human cerebellum estimated by intrinsic functional connectivity
2011 Standout
The Adaptive Brain: Aging and Neurocognitive Scaffolding
2008 Standout
Efficacy of a special Kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin — A double-blind placebo-controlled study of four weeks treatment
1996
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Novel Antipsychotic Agents with Dopamine Autoreceptor Agonist Properties: Synthesis and Pharmacology of 7-[4-(4-Phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone Derivatives
1998
Regional brain function, emotion and disorders of emotion
1999
Works of A. Klimke being referenced
Veränderungen der Serotonin-5HT2-Rezeptoren bei remittierten Patienten mit hereditärer Depression = Disturbance of serotonin 5HT2 receptors in remitted patients suffering from hereditary depressive disorder
2001
Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT
1999
Increased serum S100B in elderly, chronic schizophrenic patients: Negative correlation with deficit symptoms
2005
Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine
2005
Reversible Neutropenia during Treatment with Olanzapine: Three Case Reports
2004
Active [3H]-Dopamine Uptake Displayed by Native Lymphocyte Suspensions is Mainly Due to Contaminating Platelets
1998
Uptake of Clozapine into HL-60 Promyelocytic Leukaemia Cells
2002
Neuropsychological impairments predict the clinical course in schizophrenia
2008
Clozapine therapy raises serum concentrations of high sensitive C-reactive protein in schizophrenic patients
2010
Initial Improvement as a Criterion for Drug Choice in Acute Schizophrenia
1993
Left-right asymmetry of striatal dopamine D2 receptors
1998
Increased serum interleukin-I? and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication
2005
The Efficacy of Cavain in Patients Suffering from Anxiety
1989
Antipsychotic Efficacy of the Dopaminergic Autoreceptor Agonist EMD 49980 (Roxindol)
1991
In VivoEvidence for the Involvement of Dopamine-D2Receptors in Striatum and Anterior Cingulate Gyrus in Major Depression
1997
Randomized double blind comparison of olanzapine vs. clozapine on subjective well‐being and clinical outcome in patients with schizophrenia
2005
A functional-structural model to understand cardiac autonomic nervous system (ANS) dysregulation in affective illness and to elucidate the ANS effects of antidepressive treatment.
2004
[Clinical impact of cerebral dopamine-D2 receptor scintigraphy].
1998
Disturbance of serotonin 5HT2 receptors in remitted patients suffering from hereditary depressive disorder
2001